Use of 2'-fluoro-5-methyl-β-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus

Antimicrobial Agents and Chemotherapy

Volumn 39, Issue 4, 1995, Pages 979-981

  Chu, C K ^a   Ma, T ^a   Shanmuganathan, K ^a   Wang, C ^a   Xiang, Y ^a   Pai, S B ^a   Yao , G Q ^a   Sommadossi, J P ^a   Cheng, Y C ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLEVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; EPSTEIN BARR VIRUS; HEPATITIS B; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0028943355     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.39.4.979     Document Type: Article

References (0)